Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Stock Just Soared by 20%: Should You Buy Now?

TheMotleyFool

0 0

This Stock Just Soared by 20%: Should You Buy Now?: https://g.foolcdn.com/editorial/images/714068/person-getting-vaccinated.jpg

Biotech company Moderna (NASDAQ: MRNA) has been southbound for most of the year, but the vaccine maker seems to be ending 2022 on a high note. On Dec. 13, the company's shares soared by more than 20% in one day. As is usually the case with biotechs, Moderna had good news from the clinic to thank for that impressive one-day rally (more on that later).

But the company is still facing issues, including a potential drop in sales of its prized coronavirus vaccines. Are Moderna's shares still worth buying right now? Let's find out.